logo
[breadcrumb_custom]

Tag: Aethlon stock

Stock Investing

Let’s take a look at why Aethlon Medical, Inc. (Nasdaq: AEMD) dropped its value

Aethlon Medical, Inc. (Nasdaq: AEMD), closed down -11.16% to $2.07 at the last close, after a clinical medical product and technology organization concentrating on unmet needs of infectious diseases, oncology and inflammation, confirmed that the first patient had been treated in the Company’s first-in-human Early Feasibility Study (EFS) applying the HEMOPURIFIER to patients with recurrent and metastatic squamous cell carcinoma of the neck. The study is enrolling patients at UPMC Hillman Cancer Center in Pittsburgh, PA. EFS is an open-label, and a single-center trial is equivalent to Phase 1 clinical trials for drugs or biologics. The study evaluates the HEMOPURIFIER